DIL
IMVT icon

Deeter Investments LLP’s Immunovant IMVT Stock Holding History

Deeter Investments LLP’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$941K Buy
+37,000
New +$825K 0.2% 60

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Deeter Investments LLP's IMVT Position: Q4 2025 in Review

Deeter Investments LLP opened a new position in Immunovant (IMVT) in Q4 2025: 37,000 shares worth $941K. The stake represents 0.2% of the portfolio and ranks #60 among its holdings.

197 funds tracked by Wall St. Rank hold IMVT as of Q4 2025.

  • Deeter Investments LLP held 37,000 shares of Immunovant worth $941K as of Q4 2025.
  • Immunovant was a new Deeter Investments LLP position in Q4 2025.
  • Immunovant made up 0.2% of Deeter Investments LLP's portfolio in Q4 2025, its #60 holding.
  • 197 funds tracked by Wall St. Rank held Immunovant as of Q4 2025.

Based on Deeter Investments LLP's 13F filing for Q4 2025, filed 28 Aug 2026.